Keyphrases
Peru
100%
Multidrug-resistant Tuberculosis (MDR-TB)
58%
Lima
35%
AIDS/HIV
25%
Prospective Cohort Study
25%
Drug Susceptibility Testing
21%
Tuberculosis
20%
Natural Areas
16%
Laboratory Information System
16%
Paragonimus
16%
Cajamarca
16%
Trypanosoma Cruzi (T. cruzi)
16%
Triatomines
16%
Acanthocephalan
16%
Enterobacteria
14%
Risk Factors
14%
XDR-tuberculosis
14%
Health Centers
12%
Second-line Drugs
12%
Sputum Culture Conversion
11%
Fecal Samples
11%
Multidrug-resistant
10%
CTX-M
10%
Philippines
10%
South Africa
10%
Online Laboratory
10%
Dengue
9%
Tuberculosis Patients
9%
Extensively Drug-resistant Tuberculosis
9%
Second-line Injectable Drugs
8%
Control Actions
8%
Drug Resistance
8%
CTX-M β-lactamases
8%
Quinolones
8%
Plasmid Mediated Resistance
8%
Transmission Hotspots
8%
End of Treatment
8%
Routinely Collected Data
8%
Dengue Vector Control
8%
Highly Active Antiretroviral Therapy (HAART)
8%
Penetration Pathways
8%
Experimental Animals
8%
β-lactamase
8%
Antimicrobial Resistance
8%
F. Hepatica
8%
Experimental Verification
8%
Children's Health
8%
Fasciola Hepatica
8%
Influenza A H1N1
8%
Extended-spectrum beta-lactamase-producing Escherichia Coli
8%
Scientific Production
8%
Bellis
8%
Recurrent Diarrhoea
8%
Resource-poor Environments
8%
Livestock
8%
Treatment Outcome
8%
Community Members
8%
Northern Peru
8%
Virus Transmission
8%
Healthcare Quality Improvement
8%
Oncology Patients
8%
Phylogenetic Groups
8%
Dengue Virus
8%
Treatment Response
8%
Healthcare Workers
8%
Transmission Potential
8%
Communication Delay
8%
Human Toxocariasis
8%
Dot-ELISA
8%
Bedaquiline
8%
AIDS Patients
8%
Cluster Randomized Trial
8%
Quality of Care
8%
Bibliometric Analysis
8%
Functional Requirements
8%
Usage Statistics
8%
Observational Cohort Study
8%
Prognostic Marker
8%
Rural Population
8%
Tuberculosis Research
8%
Healthcare Worker Infection
8%
Infection Control Practices
8%
Phylogeny
8%
Tuberculosis Transmission
8%
ELISA Test
8%
Extended-spectrum beta-lactamase-producing Enterobacteriaceae
8%
Future Burden
8%
Mathematical Modeling Studies
8%
India
8%
Full Information
8%
New Host
8%
Fluoroquinolones
7%
Control Strategy
7%
Salud
7%
Ciprofloxacin
7%
Peruvian
7%
Humidity
6%
Serology
6%
Stool Samples
6%
Treatment Efficacy
6%
Medicine and Dentistry
Multidrug Resistant Tuberculosis
47%
Prospective Cohort Study
25%
Drug Sensitivity
18%
Disease
16%
Human Immunodeficiency Virus
15%
Culture Conversion
14%
Sputum Culture
12%
Randomized Controlled Trial
9%
Extensively Drug Resistant Tuberculosis
9%
Infection
9%
Hazard Ratio
8%
Child Health
8%
Diarrhea
8%
Highly Active Antiretroviral Therapy
8%
Paragonimus
8%
Paragonimiasis
8%
Laboratory Information System
8%
Treatment Response
8%
HIV/AIDS
8%
Cohort Study
8%
Prevalence
8%
Extended Spectrum Beta Lactamase Producing Enterobacteriaceae
8%
Drug Resistance
8%
Quinolone Derivative
6%
Chronic Diarrhea
5%
Isospora belli
5%
Sputum
5%
Tuberculosis Treatment
5%